WO2008040387A1 - Process for chromosomal integration and dna sequence replacement in clostridia - Google Patents
Process for chromosomal integration and dna sequence replacement in clostridia Download PDFInfo
- Publication number
- WO2008040387A1 WO2008040387A1 PCT/EP2006/066997 EP2006066997W WO2008040387A1 WO 2008040387 A1 WO2008040387 A1 WO 2008040387A1 EP 2006066997 W EP2006066997 W EP 2006066997W WO 2008040387 A1 WO2008040387 A1 WO 2008040387A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- clostridium
- process according
- gene
- strain
- vector
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
Definitions
- Clostridia are gram positive, anaerobic and low GC bacteria that are widely used in industry for their capacities to produce solvents, in particular butanol, ethanol and acetone, but also diols like 1,3 propanediol, organic acids like acetic, butyric or lactic acid and vaccines.
- Clostridium strains are genetically modified in order to improve their industrial capabilities.
- homologous recombination is the most used technique in all kinds of organisms. Transformation and homologous recombination in several microorganisms have been extensively described in the art. See for example (Datsenko and Wanner ; PNAS, 2000) and (Fabret et al, Molecular Microbiology, 2002).
- Clostridia are not naturally transformable and currently available methods for their transformation are inefficient and do not permit the introduction of multiple mutations. This has hampered industrial developments in this field.
- Clostridia commonly produce extracellular DNAses and restriction enzymes that degrade foreign DNA before and after introduction into the cells for transformation.
- Classic methods based on the introduction of PCR fragments that work well in many microorganisms such as E. coli or yeast, are not feasible in these organisms, since the extracellular and intracellular half life of the DNA construct to be recombined is too short and recombination efficiency is generally low.
- these difficulties have been circumvented by using vectors that replicate in the host thus increasing the likelihood of the recombination event. Nevertheless after the recombination event the vector that now carries the intact target DNA sequence has to be eliminated.
- the so far described recombinant strains are all resistant to MLS or chloramphenicol and the corresponding marker genes can not be removed after the recombination event has occurred. This limits the number of possible recombinations to the number of available resistance markers in these bacteria to a maximum of 3. Furthermore, for the industrial use of these bacteria, it might be useful to have markerless strains in order to avoid the release of antibiotic resistance genes into fermentation media.
- the present invention is related to a new method for replacing or deleting DNA sequences in Clostridia, easy to perform and applicable at an industrial level. This method is useful to modify several genetic loci in Clostridia in a routine manner.
- This method is based on a replicative vector useful for the transformation of Clostridia with high efficiency.
- Clostridia Efficient introduction of multiple mutations into Clostridia should enable industry to improve existing industrial strains and to develop new processes.
- the invention provides a process for the replacement of a target DNA sequence by homologous recombination in Clostridia, comprising :
- the term « replacement » of a target DNA sequence means that a different sequence than the original one is introduced at the locus of the target DNA sequence.
- a DNA sequence is defined as a gene, or an intergenic sequence. Both can comprise promoter or regulatory sequences.
- target DNA sequence means any gene, intergenic region, promoter or regulatory sequence of interest chosen by the man skilled in the art. It means in particular genes coding for proteins of interest, for example enzymes involved in the cellular metabolism.
- the substituted / inserted DNA sequence may be coding or not. It may be a mutated sequence of the target gene, promoter or regulatory sequence and/or a marker such as an antibiotic resistance gene or a color generating enzyme. It may be longer or shorter than the replaced sequence, depending on the distance separating the two homologous regions.
- the expression of the target gene is usually perturbed, partially or completely suppressed, or increased.
- homologous recombination refers to the event of substitution of a segment of DNA by another one that possesses identical regions (homologous) or nearly so. This event is also called DNA crossover.
- transformation » refers to the incorporation of exogenous nucleic acid by a cell, this acquisition of new genes being transitory (if the vector carrying genes is cured) or permanent (in the case the exogenous DNA is integrated chromosomally).
- vector » refers to an extra-chromosomal element carrying genes or cassettes, that is usually in the form of a circular double-stranded DNA molecules, but may be a single strand DNA molecule, too. Both terms “vector” and “plasmid” are used indifferently.
- the vector according to the invention is a replicative vector. It comprises at least one origin of replication, and preferentially several replicative origins, allowing it to be functional in different species.
- a preferred vector may comprise two replicative origins :
- sequences homologous to a target DNA sequence » refers to sequences with high sequence similarity with selected regions of the target sequence.
- marker gene » refers to a sequence coding for a marker protein under the control of regulatory elements functional in Clostridia. Such proteins are well known in the art. For example the man skilled in the art may use an antibiotic resistance gene, a fluorescent or colored marker, or a marker of auxotrophy. Examples of useful marker genes will be given below.
- the vector now carries the intact target DNA sequence and consequently has to be eliminated.
- the elimination of a replicative vector generally happens with successive cultures of clones, followed by negative or positive selection of clones having eliminated this vector.
- the elimination of the vector can also be an active step of the process, with the use of endonucleases that specifically cleaves DNA sequences present in the vector. Once the vector is cured, strains do not express the second marker gene anymore, and can be selected on this characteristic.
- the second marker gene is an antibiotic resistance gene.
- antibiotic resistance genes the man skilled in the art would know which is the most appropriate.
- CatP gene giving the resistance to chloramphenicol and thiamphenicol
- MLS R gene giving resistance to erythromycin.
- the second marker gene is a counter-selectable marker gene.
- a counter-selectable marker is a gene whose presence is lethal to the host organism under certain circumstances, such as the presence of its cognate substrate. Counter-selectable markers can be used as a positive selection for the loss of the plasmid.
- the counter-selectable marker gene is a gene that restores the activity of an absent or deleted non-essential endogenous gene.
- counterselectable markers are the genes that confer sucrose, streptomycin, or fusaric acid sensitivity. They have been used to construct mutants or vaccine strains in several bacterial strains. For details see the review by Reyrat et at., 1998, Infection and Immunity.
- Counterselectable markers that can be used in Clostridia include genes giving sensitivity to 5-fiuoro-uracile (5-FU), gamma-glutamyl hydrazide (GBS) or 8-aza-2,6- diaminopurine (8 ADP).
- the counter-selectable marker is the upp gene, which encodes uracil phosphoribosyl-transferase that promotes transformation of 5-fiuoro-uracile (5-FU) to a toxic product.
- Cells having Upp activity can not grow on a 5-FU medium.
- this counter-selectable marker is particularly useful when the transformed Clostridia are ⁇ upp, and consequently are able to grow on a medium comprising 5-FU before the transformation and after the elimination of the vector. Strains having eliminated the vector can be positively selected.
- the vector comprises furthermore a third marker, preferentially an antibiotic resistance gene that permits a second selection of strains sensitive to the antibiotic. This negative selection may be used in addition to the positive selection based on the upp gene.
- the vector is eliminated by digestion with endonucleases after the recombination event has occurred.
- the vector harbors DNA sequences that are recognized by restriction endonucleases and that are at the same time absent from the genome of the Clostridium species used. Therefore the vector is specifically destroyed without loss of integrity of the Clostridium genome.
- Restriction endonucleases are enzymes that cleave DNA molecules at the location of specific base sequences, the restriction endonuclease site. The expert in the field will be able to determine which restriction endonuclease site is absent from the genome of the Clostridium strain of interest. Possible restriction endonucleases that may be applied for C. acetobutylicum are Ascl, Fsel, Notl, Sfil, Srfl. In another embodiment meganucleases, which recognize large (12-45 bp) DNA target sites, such as I-Scel, HO or I-Crel may be used.
- the Clostridium strain to be transformed harbors on its genome at least one endonuclease encoding gene, which recognizes the restriction endonuclease site that is present on the vector.
- the restriction endonuclease expression is under the control of an inducible promoter.
- An inducible promoter is a DNA element that permits the conditional expression of a target sequence by adding the corresponding inducer.
- an inducible promoter system in Clostridium that is known to the expert in the field is described in Girbal et al, 2003,
- restriction endonuclease After the recombination event has occurred, and before the screening of strains that have eliminated the vector, the expression of the restriction endonuclease may be induced.
- the restriction endonuclease will cleave the vector present in the Clostridia leading to its elimination.
- restriction endonuclease encoding gene can be inserted on the genome before the introduction of the vector into the strain.
- the restriction endonuclease encoding gene may also increase the frequency of recombination before the elimination of the plasmid by increasing the amount of linear DNA in the cells that is known to recombine better than circular DNA.
- the first marker gene is an antibiotic resistance gene introduced in the middle of the replacement cassette.
- this first marker gene may be removed from the genome of the transformed Clostridium strains.
- the first marker gene may be surrounded by two recombinase target sites, and then be eliminated by action of a recombinase, after the homologous recombination event has occurred.
- the recombinase is expressed by a second vector carrying the corresponding gene, said vector being introduced into the Clostridia by transformation.
- recombinase target sites are FRT sequences.
- FLP recombinase from Saccharomyces cerevisiae is active at a particular 34 base pair DNA sequence, termed the FRT sequence (for FLP recombinase target).
- the FLP enzyme creates double-stranded breaks in the DNA strands, exchanges the ends of the first FRT with those of the second target sequence, and then reattaches the exchanged strands. This process leads to deletion of the DNA which lies between the two sites.
- sequences homologous to selected regions around the target DNA sequence may comprise mutations in up to 10% of the base pairs composing the DNA fragment used for the recombination event.
- the Clostridium strains to be transformed are deleted for the genes encoding restriction endonucleases. These strains present the advantage that they are readily transformable without any prior in vivo plasmid methylation.
- the Clostridium strains to be transformed are deleted for the genes encoding the extracellular DNAses.
- the Clostridia to be transformed are deleted for the upp gene.
- the Clostridium strains to be transformed are chosen among Clostridium acetobutylicum, Clostridium bejeirinckii, Clostridium saccharoperbutylacetonicum, Clostridium butylicum, Clostridium butyricum, Clostridium perfringens, Clostridium tetani, Clostridium sporogenes, Clostridium thermocellum, Clostridium saccharolyticum (now Thermoanaerobacter saccharolyticum), Clostridium thermosulfurogenes (now Thermoanaerobacter thermosulfurigenes), Clostridium thermohydrosulfuricum (now Thermoanaerobacter ethanolicus).
- Clostridium strain Clostridium acetobutylicum.
- the Clostridium acetobutylicum strain to be transformed is a strain ⁇ Cacl5, deleted for the gene encoding for the restriction endonuclease Cac 8241.
- This strain presents the advantage that it is readily transformable without any prior in vivo plasmid methylation.
- the Clostridium acetobutylicum strain to be transformed is a strain whose upp gene was deleted, termed ⁇ upp.
- ⁇ upp a strain whose upp gene was deleted
- Clostridium acetobutylicum strain to be transformed can also be ⁇ Cac 15 ⁇ upp.
- the process is advantageously used for successive replacement of two or more target genes by homologous recombination in the same Clostridium strain.
- the present invention also concerns a recombinant Clostridium strain susceptible to be obtained by the process according to the invention.
- the process according to the invention may be used to obtain recombinant Clostridium strains wherein the gene cac 15 was deleted (strain ⁇ cac 15), wherein the gene upp was deleted (strain ⁇ upp) and wherein both genes cac 15 and upp were deleted (strain ⁇ Cacl5 ⁇ upp).
- the present invention also concerns the vector for transforming the strain, such as described above.
- Figure 1 Map of the pUC 18-FRT-MLS2 vector
- Figure 2 Map of the pCons2-l vector.
- Figure 3 Map of the pCIP2-l vector
- Figure 4 Map of the pCons::UPP vector
- Figure 5 Map of the pCLFl vector
- Figure 6 Schematic representation of the deletion method for Clostridia. The following steps are successively performed:
- This plasmid contains an MLS r gene functional in Clostridia and flanked by two FRT sites and two Stul sites and is useful for the construction of the replacement cassettes.
- IPCR Inverse polymerase chain reaction
- Pwo DNA polymerase with pKD4 as a template plasmid (Datsenko and Wanner, 2000) and oligonucleotides PKD4.1 and PKD4.2 as primers to amplify the plasmid region with the FRT sites but without the Km r marker.
- This blunt end fragment was later ligated to the MLSr gene obtained after a HmdIII digestion of the pETSPO plasmid (Harris et al, 2002, J.
- the corresponding plasmid (pKD4-Eryl) was then used as a template to amplify the MLS r gene flanked by two FRT sites and two Stul sites in a PCR reaction using the oligonucleotides FRT-MLSR-F and FRT-MLSR-R as primers and Pwo DNA polymerase. This fragment was directly cloned into the Smal digested pUC18 to yield the pUC18-FRT- MLS2 plasmid ( Figure 1).
- PKD4.1 (SEQ ID N° 1 ) : 5 ' -ctggcgccctgagtgcttgcggcagcgtgagggg-3 ' PKD4.2 (SEQ ID N°2): 5'-agcccggggatctcatgctggagttcttcgccc-3'
- FRT-MLSR-F (SEQ ID N°3): 5 '-tacaggccttgagcgattgtgtaggctggagc-3 '
- FRT-MLSR-R (SEQ ID N°4): 5 '-aacaggcctgggatgtaacgcactgagaagccc-3 '
- This plasmid contains a pIM13 origin of replication functional in Clostridia (rolling circle mechanism of replication), a cat? gene conferring resistance to thiamphenicol and a unique Bam ⁇ site for the cloning of the replacement cassette.
- This plasmid was constructed in a two step procedure from the pETSPO plasmid (Harris et al, 2002, J. Bacteriol) to remove part of a polylinker and among others a Bam ⁇ and an EcoRI site.
- IPCR was performed with Pwo DNA polymerase with pETSPO as a template plasmid and oligonucleotides PCONSAccI and PCONSEcoRI as primers, and the PCR product was phosphorylated and ligated. After transformation of E. coli the pConsO plasmid was obtained. This plasmid was then digested with BamHl to remove the spoOA cassette,the proper DNA fragment purified and ligated to yield plasmid pCons2-l. The map of pCons2-l is given in figure 2.
- the origin of replication of pSOLl was replaced by the origin of replication of the pSOLl plasmid, a plasmid having a ⁇ mechanism of replication.
- the origin of replication of pSOLl was PCR amplified with Pwo DNA polymerase using total DNA of C. acetobutylicum as a template and oligonucleotides ori- 3-D and ori-4-R as primers.
- This PCR product was cloned in the pCR-Bluntll-TOPO and the resulting plasmid digested by EcoBJ and the 2.2 kb fragment was purified.
- ORI-3-D (SEQ ID N°7) : 5'-ccatcgatgggggtcatgcatcaatactatcccc-3' ORI-4-R (SEQ ID N°8) : 5'-gcttccctgttttaatacctttcgg-3'
- the upp gene with its own ribosome bindind site was cloned into pCons2.1 at the B cgl site just downstream of the CatP gene in order to construct an artificial operon with upp expressed under the control of the CatP promoter. In this way, no homologous regions were introduced that would allow chromosomal integration of the upp gene in the Acacl5Aupp strain in further deletion experiments, which use the upp gene as a counter selectable marker for plasmid loss.
- the upp gene with its rbs was PCR (Pfu) amplified from genomic C. acetobutylicum DNA using oligonucleotides REP-UPP F et REP-UPP R as primers.
- the 664 bp PCR-product was digested by PvuW and cloned into pCons2.1 digested by Bcgl and treated with T4 DNA Polymerase to blunt ends. In this way the pCons::UPP (see figure 4) replicative vector was obtained.
- PCR primers :
- REP-UPP F (SEQ ID N°9) : 5'- aaaa ⁇ agc ⁇ ggaggaatgaaataatgagtaaagttacac-3'
- REP-UPP R (SEQ ID N 0 IO) : 5'- aaaac;!;:U$ttattttgtaccgaataatctatctccagc-3'
- the FLPl gene of S. cerevisiae coding for the FLP recombinase was cloned in the pCons2.1 vector under the control of the promoter and RBS from the thiolase (thl) gene from C acetobutylicum permitting high expression in this organism.
- the FLPl gene was PCR (Pfu) amplified using the FLPl-D and FLPl-R oligonucleotides as primers and the pCP20 plasmid (Datsenko and Wanner, 2000) as a template.
- FLPl-D has a 5' extension including a BamHl site and the RBS sequence of thl.
- FLPl-R introduced an Sf ol site in 3' of the PCR product.
- the PCR product was digested by BamHl and Sfol and directly cloned into the pSOS95 expression vector that had been digested with the same enzymes, giving the pEX-FLPl (628 lpb) plasmid.
- Example 2 Deletion of the cacl502 gene encoding the cac824I restriction enzyme in Clostridium acetobutylicum
- Two DNA fragments surrounding the Cac824I encoding gene (CACl 502) were PCR amplified with Pwo DNA polymerase using total DNA from C acetobutylicum as template and two specific pairs of oligonucleotides as primers (see table 2).
- primers CAC IB-CAC 2 and CAC 3-CAC 4B 1493 bp and 999 bp DNA fragments were obtained, respectively.
- Both primers CAC IB and CAC 4B introduce a BamHl site while primers CAC 2 and CAC 3 have complementary 5' extended sequences which introduce a Stul site.
- DNA fragments CAC IB-CAC 2 and CAC 3-CAC 4B were joined in a PCR fusion experiment with primers CAC IB and CAC 4B and the resulting fragment was cloned in the pCR4-TOPO-Blunt vector to yield pTOPO:cacl5.
- pTOPO:cacl5 At the unique Stul site of pTOPO:cacl5, the 1372 bp Stul fragment of pUC18-FRT-MLS2 harboring the antibiotic resistance MLS r gene with FRT sequences on both sides was introduced.
- the cacl502 replacement cassette obtained after BamHl digestion of the resulting plasmid was cloned, at the BamHl, into pCons2- 1 site to yield the pREPCAC 15 plasmid and into pCIP2.1 to yield pCIPCAC 15.
- the pREPCAC15 and pCIPCAC15 plasmids were methylated in vivo and used to transform C. acetobutylicum by electroporation. After selection on Petri plates for clones resistant to erythromycin (40 ⁇ g/ml), one colony of each transformants was cultured for 24 hours in liquid synthetic medium with erythromycin at 40 ⁇ g/ml and then subcultured in liquid 2YTG medium without antibiotic.
- acetobutylicum than a rolling circle mechanism.
- the genotype of clones resistant to erythromycin and sensitive to thiamphenicol was checked by PCR analysis (with primers CAC 0 and CAC 5 located outside of the CAC 15 replacement cassette and primers CAC D and CAC R located inside of cacl502).
- Acacl5::mls R strains which have lost pREPCAC15 were isolated.
- a Acacl5::mls R strain was transformed with the pCLFl vector expressing the FLPl gene encoding the FIp recombinase from S. cerevisiae.
- thiamphenicol 50 ⁇ g/ml
- one colony was cultured on synthetic liquid medium with thiamphenicol at 50 ⁇ g/ml and appropriate dilutions were plated on RCA with thiamphenicol at 50 ⁇ g/ml.
- Thiamphenicol resistant clones were replica plated on both RCA with erythromycin at 40 ⁇ g/ml and RCA with thiamphenicol at 50 ⁇ g/ml.
- the genotype of clones with erythromycin sensitivity and thiamphenicol resistance was checked by PCR analysis with primers CAC 0 and CAC 5B. Two successive 24 hours cultures of the Acacl5 strain with erythromycin sensitivity and thiamphenicol resistance were carried out in order to loose pCLFl. The Acacl5 strain which has lost pCLFl was isolated according to its sensitivity to both erythromycin and thiamphenicol. The strain was called C. acetobutylicum MGCAcacl5. Table 2
- CAC lB 13 aaaggatccatgcacactcataaatttactgtaggaagtctg'
- CAC 3 15 ccccctttttaggcctcccctcgaacttattagaatgattaagattccgg
- CAC 4B 16 aaaggatcctcattaaatttcctccattttaagcctgtc
- CAC R 20 gttgtattggaatctttgttattatttctcc
- Example 3 Deletion of the upp gene encoding the uracil phosphoribosyl-transferase in Clostridium acetobutylicum Acacl5
- DNA fragments UPP 1-UPP 2 and UPP 3-UPP 4 were joined in a PCR fusion experiment with primers UPP 1 and UPP 4 and the resulting fragment was cloned in pCR4-TOPO-Blunt to yield pTOPO:upp.
- the 1372 bp Stul fragment of pUC18-FRT-MLS2 harboring the antibiotic resistance MLS r gene with FRT sequences on both sides was introduced.
- the upp replacement cassette obtained after BamHl digestion of the resulting plasmid was cloned into pCons2-l at the Bam ⁇ l site to yield the pREPUPP plasmid.
- the plasmid pREPUPP was used to transform C. acetobutylicum MGCAcacl5 strain by electroporation without previous in vivo methylation. After selection on Petri plates for clones resistant to erythromycin (40 ⁇ g/ml), one colony was cultured for 24 hours in liquid synthetic medium with erythromycin at 40 ⁇ g/ml and then subcultured in liquid 2YTG medium without antibiotic. Appropriate dilutions were plated on RCA with erythromycin at 40 ⁇ g/ml.
- erythromycin resistant clones were replica plated on both RCA with erythromycin at 40 ⁇ g/ml and RCA with thiamphenicol at 50 ⁇ g/ml.
- the genotype of clones resistant to erythromycin and sensitive to thiamphenicol was checked by PCR analysis (with primers UPP 0 and UPP 5 located outside of the UPP replacement cassette and primers UPP D and UPP R located inside of UPP).
- the Acacl 5Aupp: :mls R strain that has lost pREPUPP was isolated.
- the previous cac 1502 deletion was confirmed as previously described in the first example.
- the Acacl 5Aupp: :mls R strain is resistant to 400 ⁇ M 5-FU compared to 50 ⁇ M for the Acacl 5 strain.
- the Acacl 5 Aupp: :mls R strain was transformed with the pCLFl vector expressing the FLPl gene encoding the FIp recombinase from S. cerevisiae. After transformation and selection for resistance to thiamphenicol (50 ⁇ g/ml) on Petri plates, one colony was cultured in synthetic liquid medium with thiamphenicol at 50 ⁇ g/ml and appropriate dilutions were plated on RCA with thiamphenicol at 50 ⁇ g/ml. Thiamphenicol resistant clones were replica plated on both RCA with erythromycin at 40 ⁇ g/ml and RCA with thiamphenicol at 50 ⁇ g/ml.
- the genotype of clones with erythromycin sensitivity and thiamphenicol resistance was checked by PCR analysis with primers UPP 0 and UPP 5. Two successive 24 hours cultures of the Acacl 5 Aupp strain with erythromycin sensitivity and thiamphenicol resistance were carried out in order to lose pCLFl. The Acacl 5 Aupp strain that has lost pCLFl was isolated by determining its sensitivity to both erythromycin and thiamphenicol.
- UPP 4 24 aaaaggatccgctattatgaataggttaaataagtcagctgg
- Example 4 Deletion of the cac3535 gene with the use of upp and 5-fluorouracil as a positive selection for plasmid loss
- DNA fragments RM 1-RM 2 and RM 3-RM 4 were joined in a PCR fusion experiment using primers RM 1 and RM 4 and the resulting fragment was cloned in pCR4-TOPO-Blunt vector to yield the pTOPO:cac3535 plasmid.
- pTOPO:cac3535 At the unique Stul site of pTOPO:cac3535, the 1372 bp Stul fragment of pUC18-FRT-MLS2 harboring the antibiotic resistance MLS r gene with FRT sequences on both sides was introduced.
- the CAC3535 replacement cassette obtained after B ⁇ mHl digestion of the resulting plasmid was cloned into pCons::upp at the B ⁇ mHl site to yield the pREPCAC3535::upp plasmid.
- the pREPCAC3535::upp plasmid was used to transform the C. acetobutylicum MGCAcacl5Aupp strain by electroporation. After selection for erythromycin (40 ⁇ g/ml) resistant clones on Petri plates, one colony was cultured for 24 hours in liquid synthetic medium with erythromycin at 40 ⁇ g/ml and 100 ⁇ l of undiluted culture were plated on RCA with erythromycin at 40 ⁇ g/ml and 5-FU at 400 ⁇ M.
- Colonies resistant to both erythromycin and 5-FU were replica plated on both RCA with erythromycin at 40 ⁇ g/ml and RCA with thiamphenicol at 50 ⁇ g/ml to verify that 5-FU resistance is associated with thiamphenicol sensitivity.
- the genotype of clones resistant to erythromycin and sensitive to thiamphenicol was checked by PCR analysis (with primers RM 0 and RM 5 located outside of the cac3535 replacement cassette and primers RM D and RM R located inside of cac3535 gene). In this way the Acacl 5AuppAcac35 : :mls R strain that has lost pREPCAC3535::upp was isolated.
- Girbal L Mortier-Barriere L Raynaud F, Rouanet C, Croux C, Soucaille P.
- spoOA Disruption of the gene (spoOA) encoding sporulation transcription factor blocks endospore formation and enterotoxin production in enterotoxigenic Clostridium perfringens type A. FEMS Microbiol Lett. 2004 Apr 15;233(2):233-40.
- the luxS gene is involved in cell-cell signalling for toxin production in Clostridium perfringens. MoI Microbiol. 2002 Apr;44(l): 171-9.
- Counterselectable markers untapped tools for bacterial genetics and pathogenesis.
- Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops.
- the CcpA protein is necessary for efficient sporulation and enterotoxin gene (cpe) regulation in Clostridium perfringens. J Bacteriol. 2004 Aug;186(16):5221-9.
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2009003605A MX2009003605A (en) | 2006-10-03 | 2006-10-03 | Process for chromosomal integration and dna sequence replacement in clostridia. |
CN2006800560079A CN101528930B (en) | 2006-10-03 | 2006-10-03 | Process for chromosomal integration and DNA sequence replacement in clostridia |
KR1020097006800A KR101311619B1 (en) | 2006-10-03 | 2006-10-03 | Process for chromosomal integration and DNA sequence replacement in Clostridia |
AU2006349179A AU2006349179A1 (en) | 2006-10-03 | 2006-10-03 | Process for chromosomal integration and DNA sequence replacement in Clostridia |
PCT/EP2006/066997 WO2008040387A1 (en) | 2006-10-03 | 2006-10-03 | Process for chromosomal integration and dna sequence replacement in clostridia |
JP2009530760A JP5203375B2 (en) | 2006-10-03 | 2006-10-03 | Chromosome uptake and DNA sequence replacement in Clostridium bacteria |
CA002665120A CA2665120A1 (en) | 2006-10-03 | 2006-10-03 | Process for chromosomal integration and dna sequence replacement in clostridia |
BRPI0622182-3A BRPI0622182B1 (en) | 2006-10-03 | 2006-10-03 | Process for replacing a target DNA sequence by homologous recombination in Clostridia, recombinant Clostridium strain and vector for replacing a target DNA sequence by homologous recombination in Clostridia |
US11/737,025 US8168434B2 (en) | 2006-10-03 | 2007-04-18 | Process for chromosomal integration and DNA sequence replacement in Clostridia |
EP07107017A EP1908840B1 (en) | 2006-10-03 | 2007-04-26 | Process for chromosomal integration and DNA sequence replacement in clostridia |
DK07107017.1T DK1908840T3 (en) | 2006-10-03 | 2007-04-26 | Method for chromosomal integration and DNA replacement in clostridia |
EP10190229A EP2316952A1 (en) | 2006-10-03 | 2007-04-26 | Process for chromosomal integration and DNA sequence replacement in clostridia |
ES07107017T ES2369859T3 (en) | 2006-10-03 | 2007-04-26 | PROCEDURE FOR CHROMOSOMIC INTEGRATION AND REPLACEMENT OF DNA SEQUENCE IN CLOSTRIDIA. |
SI200730719T SI1908840T1 (en) | 2006-10-03 | 2007-04-26 | Process for chromosomal integration and DNA sequence replacement in clostridia |
AT07107017T ATE517995T1 (en) | 2006-10-03 | 2007-04-26 | PROCESS FOR CHROMOSOMAL INTEGRATION AND REPLACEMENT OF DNA SEQUENCES IN CLOSTRIDIA |
CL200702857A CL2007002857A1 (en) | 2006-10-03 | 2007-10-03 | PROCEDURE FOR THE REPLACEMENT OF A DNA SEQUENCE OBJECTIVE BY HOMOLOGICAL RECOMBINATION IN CLOSTRIDIA; AND RECOMBINANT CLOSTRIDIUM CEPA OBTAINED. |
ARP070104394A AR063126A1 (en) | 2006-10-03 | 2007-10-03 | PROCEDURE FOR CHROMOSOMIC INTEGRATION AND REPLACEMENT OF DNA SEQUENCE IN CLOSTRIDIA |
IL197844A IL197844A0 (en) | 2006-10-03 | 2009-03-26 | Process for chromosomal integration and dna sequence replacement in clostridia |
NO20091371A NO20091371L (en) | 2006-10-03 | 2009-04-03 | Process for chromosome integration and DNA sequence replacement in Clostridia |
US13/424,404 US8628967B2 (en) | 2006-10-03 | 2012-03-20 | Process for chromosomal integration and DNA sequence replacement in clostridia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2006/066997 WO2008040387A1 (en) | 2006-10-03 | 2006-10-03 | Process for chromosomal integration and dna sequence replacement in clostridia |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008040387A1 true WO2008040387A1 (en) | 2008-04-10 |
Family
ID=37605677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/066997 WO2008040387A1 (en) | 2006-10-03 | 2006-10-03 | Process for chromosomal integration and dna sequence replacement in clostridia |
Country Status (18)
Country | Link |
---|---|
US (2) | US8168434B2 (en) |
EP (2) | EP1908840B1 (en) |
JP (1) | JP5203375B2 (en) |
KR (1) | KR101311619B1 (en) |
CN (1) | CN101528930B (en) |
AR (1) | AR063126A1 (en) |
AT (1) | ATE517995T1 (en) |
AU (1) | AU2006349179A1 (en) |
BR (1) | BRPI0622182B1 (en) |
CA (1) | CA2665120A1 (en) |
CL (1) | CL2007002857A1 (en) |
DK (1) | DK1908840T3 (en) |
ES (1) | ES2369859T3 (en) |
IL (1) | IL197844A0 (en) |
MX (1) | MX2009003605A (en) |
NO (1) | NO20091371L (en) |
SI (1) | SI1908840T1 (en) |
WO (1) | WO2008040387A1 (en) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2192177A1 (en) | 2008-11-28 | 2010-06-02 | Total S.A. | Cellulase Cel5H related reagents and their use in microorganisms |
EP2194120A1 (en) | 2008-12-02 | 2010-06-09 | Total S.A. | Bioprocessing ligno-cellulose into ethanol with recombinant clostridium |
WO2010076324A1 (en) | 2008-12-31 | 2010-07-08 | Metabolic Explorer | Method for the preparation of diols |
WO2010084349A1 (en) * | 2009-01-22 | 2010-07-29 | The University Of Nottingham | Method of double crossover homologous recombination in clostridia |
EP2267141A1 (en) * | 2009-06-26 | 2010-12-29 | Metabolic Explorer | Process for the biological production of n-Butanol with high yield |
EP2267126A1 (en) * | 2009-06-26 | 2010-12-29 | Metabolic Explorer | Process for the stable gene interruption in clostridia |
WO2012001003A1 (en) | 2010-07-02 | 2012-01-05 | Metabolic Explorer | Method for the preparation of hydroxy acids |
WO2012004247A1 (en) | 2010-07-05 | 2012-01-12 | Metabolic Explorer | Method for the preparation of 1,3-propanediol from sucrose |
WO2012045088A2 (en) | 2010-10-01 | 2012-04-05 | The Board Of Trustees Of The University Of Illinois | Combinatorial design of highly efficient heterologous pathways |
WO2012062832A1 (en) | 2010-11-10 | 2012-05-18 | Metabolic Explorer | Microorganisms for 1,3-propanediol production using high glycerine concentration |
WO2012069593A2 (en) | 2010-11-24 | 2012-05-31 | Novartis International Pharmaceutical Ltd. | Fusion enzymes |
WO2012100196A1 (en) | 2011-01-21 | 2012-07-26 | The Board Of Trustees Of The University Of Illinois | ENHANCED FERMENTATION OF CELLODEXTRINS AND β-D-GLUCOSE |
US8236994B2 (en) | 2006-10-31 | 2012-08-07 | Metabolic Explorer | Process for the biological production of 1,3-propanediol from glycerol with high yield |
WO2012109274A1 (en) | 2011-02-07 | 2012-08-16 | The Regents Of The University Of California | Enhanced cellodextrin metabolism |
WO2012112427A3 (en) * | 2011-02-14 | 2012-11-08 | Eastman Renewable Materials, Llc | Method for incorporation of recombinant dna |
EP2540834A1 (en) | 2011-06-29 | 2013-01-02 | Metabolic Explorer | Method for the preparation of 1,3-propanediol |
WO2013053824A1 (en) | 2011-10-11 | 2013-04-18 | Metabolic Explorer | New biosynthesis pathway for prenol in a recombinant microorganism |
WO2013059326A1 (en) | 2011-10-17 | 2013-04-25 | The Board Of Trustees Of The University Of Illinois | Xylitol production from cellulosic biomass |
WO2013068692A1 (en) | 2011-11-08 | 2013-05-16 | Universite Joseph Fourier (Grenoble 1) | Expression cassette for modifying the genome of bacteria and for modifying a vector in a bacterial strain |
WO2013128230A1 (en) | 2012-03-02 | 2013-09-06 | Metabolic Explorer | A process for butanol production |
EP2647718A2 (en) | 2012-04-06 | 2013-10-09 | Metabolic Explorer | Process for producing 5-aminopentanoate empolying a recombinant microorganism |
WO2013155481A1 (en) | 2012-04-13 | 2013-10-17 | The Board Of Trustees Of The University Of Illinois | Improved cellodextrin transport and mixed sugar fermentation |
WO2014049382A2 (en) | 2012-09-26 | 2014-04-03 | Metabolic Explorer | Ethylenediamine fermentative production by a recombinant microorganism |
US8692024B2 (en) | 2011-02-14 | 2014-04-08 | Eastman Renewable Materials, Llc | Method of producing n-butyraldehyde |
WO2015159087A1 (en) * | 2014-04-17 | 2015-10-22 | Green Biologics Limited | Targeted mutations |
WO2017068385A1 (en) | 2015-10-23 | 2017-04-27 | Metabolic Explorer | Microorganism modified for the assimilation of levulinic acid |
WO2018150023A1 (en) | 2017-02-20 | 2018-08-23 | Metabolic Explorer | Microbial consortium comprising clostridia for 1,3-propanediol production from glycerol |
EP3438270A1 (en) | 2017-08-04 | 2019-02-06 | Metabolic Explorer | Microorganism and method for improved 1,3-propanediol production by fermentation on a culture medium with high glycerine content |
US10550396B2 (en) | 2014-04-17 | 2020-02-04 | Green Biologics Limited | Deletion mutations |
WO2020030775A1 (en) | 2018-08-10 | 2020-02-13 | Metabolic Explorer | Microorganisms with improved 1,3-propanediol and butyric acid production |
US10760100B2 (en) | 2015-07-27 | 2020-09-01 | Institut National Des Sciences Appliquees | Polypeptide having ferredoxin-NADP+ reductase activity, polynucleotide encoding the same and uses thereof |
FR3111642A1 (en) | 2020-06-23 | 2021-12-24 | IFP Energies Nouvelles | 5-FLUOROURACIL-RESISTANT BACTERIASCLOSTRIDIUM STRAINS, GENETIC TOOLS AND USES OF THEM |
WO2024056898A1 (en) | 2022-09-15 | 2024-03-21 | Institut National Des Sciences Appliquees De Toulouse | Genetically modified lignocellulolytic clostridium acetobutylicum |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7432090B2 (en) * | 2004-07-01 | 2008-10-07 | Rice University | Blocking sporulation by inhibiting SpoIIE |
WO2010022763A1 (en) * | 2008-08-25 | 2010-03-04 | Metabolic Explorer | Method for the preparation of 2-hydroxy-isobutyrate |
KR101647143B1 (en) * | 2009-09-22 | 2016-08-10 | 지에스칼텍스 주식회사 | A method for inactivating a desired gene in Bacteria beloning genus Clostridium |
US20110117655A1 (en) * | 2009-11-18 | 2011-05-19 | Bryan Tracy | Methods and compositions for genetically manipulating clostridia and related bacteria with homologous recombination associated proteins |
CN102559704B (en) * | 2010-12-23 | 2014-08-27 | 中国科学院上海生命科学研究院 | Method for knocking out gene in clostridium acetobutylicum |
CN103125447B (en) * | 2011-11-24 | 2014-10-15 | 上海西普尔-必凯实验动物有限公司 | Construction for number 1 chromosome substitution laboratory mouse strain C57BL/6-Chr1C3H/HeJ |
WO2013133882A2 (en) * | 2011-12-16 | 2013-09-12 | University Of Delaware | Recombinant clostridium organism and method for isolation of double-crossover allelic exchange mutants |
CN103719021B (en) * | 2012-10-10 | 2017-06-20 | 上海西普尔-必凯实验动物有限公司 | No. 1 chromosome replaces the structure of the Chr1 of wild house mice strain C57BL/6. Zaozhuang 2 |
EP3044591B1 (en) * | 2013-09-12 | 2018-08-29 | LanzaTech New Zealand Limited | Recombinant microorganisms and methods of use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001071040A2 (en) * | 2000-03-23 | 2001-09-27 | E.I. Dupont De Nemours And Company | Method for determination of gene function |
WO2001077319A2 (en) * | 2000-04-07 | 2001-10-18 | Microbiological Research Authority | Genetic manipulation of clostridium difficile |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0414832D0 (en) * | 2004-07-01 | 2004-08-04 | Cobra Biolog Ltd | Process for the removal of selectable marker gene sequences |
-
2006
- 2006-10-03 JP JP2009530760A patent/JP5203375B2/en active Active
- 2006-10-03 WO PCT/EP2006/066997 patent/WO2008040387A1/en active Application Filing
- 2006-10-03 MX MX2009003605A patent/MX2009003605A/en active IP Right Grant
- 2006-10-03 CN CN2006800560079A patent/CN101528930B/en active Active
- 2006-10-03 KR KR1020097006800A patent/KR101311619B1/en active IP Right Grant
- 2006-10-03 AU AU2006349179A patent/AU2006349179A1/en not_active Abandoned
- 2006-10-03 BR BRPI0622182-3A patent/BRPI0622182B1/en not_active IP Right Cessation
- 2006-10-03 CA CA002665120A patent/CA2665120A1/en not_active Abandoned
-
2007
- 2007-04-18 US US11/737,025 patent/US8168434B2/en not_active Expired - Fee Related
- 2007-04-26 AT AT07107017T patent/ATE517995T1/en not_active IP Right Cessation
- 2007-04-26 EP EP07107017A patent/EP1908840B1/en not_active Not-in-force
- 2007-04-26 ES ES07107017T patent/ES2369859T3/en active Active
- 2007-04-26 EP EP10190229A patent/EP2316952A1/en not_active Withdrawn
- 2007-04-26 SI SI200730719T patent/SI1908840T1/en unknown
- 2007-04-26 DK DK07107017.1T patent/DK1908840T3/en active
- 2007-10-03 CL CL200702857A patent/CL2007002857A1/en unknown
- 2007-10-03 AR ARP070104394A patent/AR063126A1/en unknown
-
2009
- 2009-03-26 IL IL197844A patent/IL197844A0/en unknown
- 2009-04-03 NO NO20091371A patent/NO20091371L/en not_active Application Discontinuation
-
2012
- 2012-03-20 US US13/424,404 patent/US8628967B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001071040A2 (en) * | 2000-03-23 | 2001-09-27 | E.I. Dupont De Nemours And Company | Method for determination of gene function |
WO2001077319A2 (en) * | 2000-04-07 | 2001-10-18 | Microbiological Research Authority | Genetic manipulation of clostridium difficile |
Non-Patent Citations (5)
Title |
---|
BISWAS I ET AL: "HIGH-EFFICIENCY GENE INACTIVATION AND REPLACEMENT SYSTEM FOR GRAM-POSITIVE BACTERIA", JOURNAL OF BACTERIOLOGY, WASHINGTON, DC, US, vol. 175, no. 11, 1 June 1993 (1993-06-01), pages 3628 - 3635, XP000563688, ISSN: 0021-9193 * |
FABRET CELINE ET AL: "A new mutation delivery system for genome-scale approaches in Bacillus subtilis", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, GB, vol. 46, no. 1, October 2002 (2002-10-01), pages 25 - 36, XP002315034, ISSN: 0950-382X * |
HARRIS LATONIA M ET AL: "Northern, morphological, and fermentation analysis of spo0A inactivation and overexpression in Clostridium acetobutylicum ATCC 824", JOURNAL OF BACTERIOLOGY, vol. 184, no. 13, July 2002 (2002-07-01), pages 3586 - 3597, XP002415781, ISSN: 0021-9193 * |
ROOD J I ET AL: "MOLECULAR GENETICS AND PATHOGENESIS OF CLOSTRIDIUM-PERFRINGENS", MICROBIOLOGICAL REVIEWS, vol. 55, no. 4, 1991, pages 621 - 648, XP002415782, ISSN: 0146-0749 * |
WILKINSON, SHANE R AND YOUNG, MICHAEL: "Targeted integration of genes into the clostridium acetobutylicum chromosome", MICROBIOLOGY, vol. 140, 1994, pages 89 - 95, XP001248444 * |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8236994B2 (en) | 2006-10-31 | 2012-08-07 | Metabolic Explorer | Process for the biological production of 1,3-propanediol from glycerol with high yield |
EP2192177A1 (en) | 2008-11-28 | 2010-06-02 | Total S.A. | Cellulase Cel5H related reagents and their use in microorganisms |
EP2194120A1 (en) | 2008-12-02 | 2010-06-09 | Total S.A. | Bioprocessing ligno-cellulose into ethanol with recombinant clostridium |
WO2010076324A1 (en) | 2008-12-31 | 2010-07-08 | Metabolic Explorer | Method for the preparation of diols |
US9121041B2 (en) | 2008-12-31 | 2015-09-01 | Metabolic Explorer | Method for the preparation of diols |
CN102361986A (en) * | 2009-01-22 | 2012-02-22 | 诺丁汉大学 | Method of double crossover homologous recombination in clostridia |
WO2010084349A1 (en) * | 2009-01-22 | 2010-07-29 | The University Of Nottingham | Method of double crossover homologous recombination in clostridia |
EP2267141A1 (en) * | 2009-06-26 | 2010-12-29 | Metabolic Explorer | Process for the biological production of n-Butanol with high yield |
EP2267126A1 (en) * | 2009-06-26 | 2010-12-29 | Metabolic Explorer | Process for the stable gene interruption in clostridia |
WO2012001003A1 (en) | 2010-07-02 | 2012-01-05 | Metabolic Explorer | Method for the preparation of hydroxy acids |
US8911978B2 (en) | 2010-07-02 | 2014-12-16 | Metabolic Explorer | Method for the preparation of hydroxy acids |
WO2012004247A1 (en) | 2010-07-05 | 2012-01-12 | Metabolic Explorer | Method for the preparation of 1,3-propanediol from sucrose |
US8900838B2 (en) | 2010-07-05 | 2014-12-02 | Metabolic Exployer | Method for the preparation of 1,3-propanediol from sucrose |
WO2012045088A2 (en) | 2010-10-01 | 2012-04-05 | The Board Of Trustees Of The University Of Illinois | Combinatorial design of highly efficient heterologous pathways |
WO2012062832A1 (en) | 2010-11-10 | 2012-05-18 | Metabolic Explorer | Microorganisms for 1,3-propanediol production using high glycerine concentration |
EP3012325A1 (en) | 2010-11-10 | 2016-04-27 | Metabolic Explorer | Microorganisms for 1,3-propanediol production using high glycerine concentration |
WO2012069593A2 (en) | 2010-11-24 | 2012-05-31 | Novartis International Pharmaceutical Ltd. | Fusion enzymes |
WO2012100196A1 (en) | 2011-01-21 | 2012-07-26 | The Board Of Trustees Of The University Of Illinois | ENHANCED FERMENTATION OF CELLODEXTRINS AND β-D-GLUCOSE |
WO2012109274A1 (en) | 2011-02-07 | 2012-08-16 | The Regents Of The University Of California | Enhanced cellodextrin metabolism |
US8692024B2 (en) | 2011-02-14 | 2014-04-08 | Eastman Renewable Materials, Llc | Method of producing n-butyraldehyde |
WO2012112427A3 (en) * | 2011-02-14 | 2012-11-08 | Eastman Renewable Materials, Llc | Method for incorporation of recombinant dna |
US9267106B2 (en) | 2011-02-14 | 2016-02-23 | Eastman Renewable Materials, Llc | Method for incorporation of recombinant DNA |
EP2540834A1 (en) | 2011-06-29 | 2013-01-02 | Metabolic Explorer | Method for the preparation of 1,3-propanediol |
WO2013053824A1 (en) | 2011-10-11 | 2013-04-18 | Metabolic Explorer | New biosynthesis pathway for prenol in a recombinant microorganism |
US9410164B2 (en) | 2011-10-11 | 2016-08-09 | Metabolic Explorer | Biosynthesis pathway for prenol in a recombinant microorganism |
WO2013059326A1 (en) | 2011-10-17 | 2013-04-25 | The Board Of Trustees Of The University Of Illinois | Xylitol production from cellulosic biomass |
WO2013068692A1 (en) | 2011-11-08 | 2013-05-16 | Universite Joseph Fourier (Grenoble 1) | Expression cassette for modifying the genome of bacteria and for modifying a vector in a bacterial strain |
WO2013128230A1 (en) | 2012-03-02 | 2013-09-06 | Metabolic Explorer | A process for butanol production |
US9434963B2 (en) | 2012-03-02 | 2016-09-06 | Metabolic Explorer | Process for butanol production |
EP2647718A2 (en) | 2012-04-06 | 2013-10-09 | Metabolic Explorer | Process for producing 5-aminopentanoate empolying a recombinant microorganism |
WO2013155481A1 (en) | 2012-04-13 | 2013-10-17 | The Board Of Trustees Of The University Of Illinois | Improved cellodextrin transport and mixed sugar fermentation |
WO2014049382A2 (en) | 2012-09-26 | 2014-04-03 | Metabolic Explorer | Ethylenediamine fermentative production by a recombinant microorganism |
US10508271B2 (en) | 2014-04-17 | 2019-12-17 | Green Biologics Limited | Targeted mutations |
US10550396B2 (en) | 2014-04-17 | 2020-02-04 | Green Biologics Limited | Deletion mutations |
WO2015159087A1 (en) * | 2014-04-17 | 2015-10-22 | Green Biologics Limited | Targeted mutations |
US10760100B2 (en) | 2015-07-27 | 2020-09-01 | Institut National Des Sciences Appliquees | Polypeptide having ferredoxin-NADP+ reductase activity, polynucleotide encoding the same and uses thereof |
WO2017068385A1 (en) | 2015-10-23 | 2017-04-27 | Metabolic Explorer | Microorganism modified for the assimilation of levulinic acid |
US10801050B2 (en) | 2015-10-23 | 2020-10-13 | Metabolic Explorer | Microorganism modified for the assimilation of levulinic acid |
US10982237B2 (en) | 2017-02-20 | 2021-04-20 | Metabolic Explorer | Microbial consortium for 1,3-propanediol production using high glycerol concentration |
WO2018150023A1 (en) | 2017-02-20 | 2018-08-23 | Metabolic Explorer | Microbial consortium comprising clostridia for 1,3-propanediol production from glycerol |
EP3438270A1 (en) | 2017-08-04 | 2019-02-06 | Metabolic Explorer | Microorganism and method for improved 1,3-propanediol production by fermentation on a culture medium with high glycerine content |
WO2019025580A1 (en) | 2017-08-04 | 2019-02-07 | Metabolic Explorer | Microorganism and method for improved 1,3-propanediol production by fermentation on a culture medium with high glycerine content |
WO2020030775A1 (en) | 2018-08-10 | 2020-02-13 | Metabolic Explorer | Microorganisms with improved 1,3-propanediol and butyric acid production |
US11814663B2 (en) | 2018-08-10 | 2023-11-14 | Metabolic Explorer | Microorganisms with improved 1,3-propanediol and butyric acid production |
FR3111642A1 (en) | 2020-06-23 | 2021-12-24 | IFP Energies Nouvelles | 5-FLUOROURACIL-RESISTANT BACTERIASCLOSTRIDIUM STRAINS, GENETIC TOOLS AND USES OF THEM |
WO2021260322A1 (en) | 2020-06-23 | 2021-12-30 | IFP Energies Nouvelles | Strains of clostridium bacteria resistant to 5-fluorouracil, genetic tools and uses thereof |
WO2024056898A1 (en) | 2022-09-15 | 2024-03-21 | Institut National Des Sciences Appliquees De Toulouse | Genetically modified lignocellulolytic clostridium acetobutylicum |
Also Published As
Publication number | Publication date |
---|---|
CA2665120A1 (en) | 2008-04-10 |
JP5203375B2 (en) | 2013-06-05 |
US8628967B2 (en) | 2014-01-14 |
EP1908840A1 (en) | 2008-04-09 |
BRPI0622182A2 (en) | 2011-12-27 |
CL2007002857A1 (en) | 2008-04-18 |
IL197844A0 (en) | 2011-08-01 |
KR101311619B1 (en) | 2013-09-26 |
SI1908840T1 (en) | 2011-10-28 |
DK1908840T3 (en) | 2011-09-19 |
KR20090086939A (en) | 2009-08-14 |
AR063126A1 (en) | 2008-12-30 |
US20080085558A1 (en) | 2008-04-10 |
EP2316952A1 (en) | 2011-05-04 |
MX2009003605A (en) | 2009-04-22 |
US8168434B2 (en) | 2012-05-01 |
AU2006349179A1 (en) | 2008-04-10 |
NO20091371L (en) | 2009-04-03 |
ES2369859T3 (en) | 2011-12-07 |
BRPI0622182B1 (en) | 2018-07-31 |
EP1908840B1 (en) | 2011-07-27 |
CN101528930B (en) | 2013-12-11 |
CN101528930A (en) | 2009-09-09 |
EP1908840A8 (en) | 2008-06-25 |
ATE517995T1 (en) | 2011-08-15 |
US20120190116A1 (en) | 2012-07-26 |
JP2010505398A (en) | 2010-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8628967B2 (en) | Process for chromosomal integration and DNA sequence replacement in clostridia | |
US20240002835A1 (en) | Genetic tool for the transformation of clostridium bacteria | |
TWI608100B (en) | Cas9 expression plasmid, gene editing system of escherichia coli and method thereof | |
US11946067B2 (en) | Optimized genetic tool for modifying Clostridium bacteria | |
US8753846B2 (en) | Methods of modifying nucleic acids in host cells | |
US20120100616A1 (en) | Method of double crossover homologous recombination in clostridia | |
EP2206788B1 (en) | Recombinant microorganism | |
EP2267126A1 (en) | Process for the stable gene interruption in clostridia | |
KR20150142305A (en) | Method for Regulating Gene Expression Using Synthetic Regulatory Small RNA in Clostridia | |
US20100330678A1 (en) | Process for the stable gene interruption in clostridia | |
US20230109758A1 (en) | Genetically modified clostridium bacteria, preparation and uses of same | |
CN108929882B (en) | Gene editing method and application of bacillus licheniformis | |
US20110256604A1 (en) | Generation of asporogenous solventogenic clostridia | |
US20220243170A1 (en) | Optimized genetic tool for modifying bacteria | |
Yamamoto et al. | Identification of pTi-SAKURA DNA region conferring enhancement of plasmid incompatibility and stability | |
RU2464317C2 (en) | Method of chromosomal integration and replacement of dna sequence in clostridia | |
Schwarz et al. | New tools for the genetic modification of industrial Clostridia | |
Meijer et al. | Alternative, RecA-mediated pathway for the initiation of lagging strand synthesis of the broad-host-range rolling circle plasmid pMV158 in Bacillus subtilis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680056007.9 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06793954 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006349179 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2665120 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2009530760 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/003605 Country of ref document: MX Ref document number: 1020097006800 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2124/CHENP/2009 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2006349179 Country of ref document: AU Date of ref document: 20061003 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2009116513 Country of ref document: RU Kind code of ref document: A |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06793954 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: PI0622182 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090402 |